| RS1567411469 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal recessive nonsyndromic hearing loss 86, Autosomal dominant nonsyndromic hearing loss 65 |
| RS1567412639 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1567412736 |
TBC1D24
|
Health Risk |
Pathogenic |
— |
| RS1567413218 |
TBC1D24
|
Health Risk |
Pathogenic |
Autosomal dominant nonsyndromic hearing loss 65, Developmental and epileptic encephalopathy |
| RS1567413573 |
IFT140
|
Health Risk |
Pathogenic |
Renal cyst, Renal cyst |
| RS1567415157 |
CIITA
|
Health Risk |
Pathogenic |
MHC class II deficiency, MHC class II deficiency |
| RS1567415595 |
THOC6
|
Health Risk |
Likely pathogenic |
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome, THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome |
| RS1567415819 |
THOC6
|
Health Risk |
Pathogenic/Likely pathogenic |
THOC6-related disorder, THOC6-related disorder |
| RS1567416845 |
THOC6
|
Health Risk |
Pathogenic |
THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome, THOC6-related developmental delay-microcephaly-facial dysmorphism syndrome |
| RS1567417422 |
CNOT1
|
Health Risk |
Pathogenic |
Holoprosencephaly sequence, Holoprosencephaly 12 with or without pancreatic agenesis |
| RS1567423240 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567423490 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1567423904 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567426711 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1567427651 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1567428094 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567430070 |
BBS4
|
Health Risk |
Pathogenic |
Bardet-Biedl syndrome, Bardet-Biedl syndrome |
| RS1567432782 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567432890 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567437155 |
TSC2
|
Health Risk |
Pathogenic |
Lymphangiomyomatosis, Isolated focal cortical dysplasia type II |
| RS1567437393 |
SLC12A3
|
Health Risk |
Pathogenic |
— |
| RS1567437492 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567443039 |
MIR140
|
Health Risk |
Pathogenic |
Spondyloepiphyseal dysplasia MIR140 type Nishimura, Spondyloepiphyseal dysplasia |
| RS1567456901 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1567457100 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567457224 |
CDH3
|
Health Risk |
Conflicting classifications of pathogenicity |
EEM syndrome, EEM syndrome |
| RS1567458244 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567462577 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567465730 |
ABCC6
|
Health Risk |
Pathogenic/Likely pathogenic |
Arterial calcification, generalized |
| RS1567467135 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567470707 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary cancer-predisposing syndrome |
| RS1567471351 |
CDH1
|
Health Risk |
Pathogenic |
— |
| RS1567476573 |
CETP
|
Health Risk |
Pathogenic |
Hyperalphalipoproteinemia 1, Hyperalphalipoproteinemia 1 |
| RS1567479067 |
FUS
|
Health Risk |
Pathogenic |
Amyotrophic lateral sclerosis type 6, Amyotrophic lateral sclerosis type 6 |
| RS1567479117 |
IRF8
|
Health Risk |
Conflicting classifications of pathogenicity |
Immunodeficiency 32B, Mendelian susceptibility to mycobacterial diseases due to partial IRF8 deficiency |
| RS1567479853 |
ATP2A1
|
Health Risk |
Pathogenic/Likely pathogenic |
Brody myopathy, Brody myopathy |
| RS1567488305 |
GNAO1
|
Health Risk |
Conflicting classifications of pathogenicity |
Inborn genetic diseases, Early-infantile DEE |
| RS1567489890 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Cortical tubers |
| RS1567490884 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567490981 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567491395 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Giant axonal neuropathy 1 |
| RS1567494825 |
GAN
|
Health Risk |
Conflicting classifications of pathogenicity |
Giant axonal neuropathy 1, Peripheral neuropathy |
| RS1567496821 |
TSC2
|
Health Risk |
Likely pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567497647 |
TSC2
|
Health Risk |
Likely pathogenic |
— |
| RS1567498041 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567498374 |
KARS1
|
Health Risk |
Pathogenic |
Sensorineural hearing loss disorder, Lactic acidosis |
| RS1567499068 |
SCAPER
|
Health Risk |
Pathogenic |
6 conditions, 6 conditions |
| RS1567501500 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567502140 |
CDT1
|
Health Risk |
Pathogenic |
Meier-Gorlin syndrome 4, Meier-Gorlin syndrome 4 |
| RS1567502487 |
LDHD
|
Health Risk |
Likely pathogenic |
Lactic aciduria due to D-lactic acid, Abnormal circulating lactate dehydrogenase concentration |
| RS1567504268 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Tuberous sclerosis syndrome |
| RS1567504468 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567504575 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS1567504592 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1567504752 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567504890 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1567504977 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567505776 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567505832 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1567506511 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1567506566 |
CD19
|
Health Risk |
Pathogenic |
Immunodeficiency, common variable |
| RS1567506816 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567507138 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567507724 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS1567507749 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567507825 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567508847 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567508939 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567508990 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary diffuse gastric adenocarcinoma |
| RS1567509070 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1567510728 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567510759 |
ZNF469
|
Health Risk |
Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS1567510854 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567511932 |
FOXF1
|
Health Risk |
Likely pathogenic |
Alveolar capillary dysplasia with pulmonary venous misalignment, Alveolar capillary dysplasia with pulmonary venous misalignment |
| RS1567512585 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS1567512631 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Hereditary cancer-predisposing syndrome |
| RS1567513227 |
CDH1
|
Health Risk |
Pathogenic |
Hereditary diffuse gastric adenocarcinoma, CDH1-related diffuse gastric and lobular breast cancer syndrome |
| RS1567515317 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567515498 |
ZNF469
|
Health Risk |
Pathogenic |
— |
| RS1567516230 |
CDH1
|
Health Risk |
Likely pathogenic |
Hereditary diffuse gastric adenocarcinoma, Gastric cancer |
| RS1567516825 |
ZNF469
|
Health Risk |
Pathogenic/Likely pathogenic |
Brittle cornea syndrome 1, Brittle cornea syndrome 1 |
| RS1567517083 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1567517746 |
CDH1
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Hereditary diffuse gastric adenocarcinoma |
| RS1567517877 |
ZNF469
|
Health Risk |
Likely pathogenic |
— |
| RS1567518028 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567518954 |
-
|
Health Risk |
Pathogenic |
Intestinal malrotation, Intestinal malrotation |
| RS1567519109 |
GALNS
|
Health Risk |
Pathogenic |
GALNS-related disorder, GALNS-related disorder |
| RS1567519221 |
GALNS
|
Health Risk |
Conflicting classifications of pathogenicity |
Mucopolysaccharidosis, MPS-IV-A |
| RS1567520269 |
CDK10
|
Health Risk |
Pathogenic/Likely pathogenic |
Al Kaissi syndrome, Al Kaissi syndrome |
| RS1567521369 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567524236 |
TSC2
|
Health Risk |
Pathogenic |
— |
| RS1567524949 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567526805 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1567526941 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Tuberous sclerosis 2 |
| RS1567528092 |
DLG4
|
Health Risk |
Pathogenic/Likely pathogenic |
Intellectual developmental disorder 62, Intellectual developmental disorder 62 |
| RS1567528487 |
TSC2
|
Health Risk |
Pathogenic |
Tuberous sclerosis 2, Hereditary cancer-predisposing syndrome |
| RS1567530426 |
GALNS
|
Health Risk |
Pathogenic |
Mucopolysaccharidosis, MPS-IV-A |
| RS1567532079 |
DLG4
|
Health Risk |
Pathogenic |
— |
| RS1567532805 |
TSC2
|
Health Risk |
Conflicting classifications of pathogenicity |
Hereditary cancer-predisposing syndrome, Tuberous sclerosis 2 |
| RS1567533189 |
TSC2
|
Health Risk |
Pathogenic |
Autism spectrum disorder, Tuberous sclerosis syndrome |